TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - El-Serag, H. B. AU - Rudolph, K. L. PY - 2007 DA - 2007// TI - Hepatocellular carcinoma: epidemiology and molecular carcinogenesis JO - Gastroenterol VL - 132 UR - https://doi.org/10.1053/j.gastro.2007.04.061 DO - 10.1053/j.gastro.2007.04.061 ID - El-Serag2007 ER - TY - JOUR AU - El-Serag, H. B. AU - Mason, A. C. PY - 2011 DA - 2011// TI - Hepatocellular carcinoma JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMra1001683 DO - 10.1056/NEJMra1001683 ID - El-Serag2011 ER - TY - JOUR AU - Ellis, L. M. AU - Hicklin, D. J. PY - 2008 DA - 2008// TI - VEGF-targeted therapy: mechanisms of anti-tumour activity JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2403 DO - 10.1038/nrc2403 ID - Ellis2008 ER - TY - JOUR AU - Xu, W. AU - Yang, Z. AU - Lu, N. PY - 2016 DA - 2016// TI - Molecular targeted therapy for the treatment of gastric cancer JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-015-0276-9 DO - 10.1186/s13046-015-0276-9 ID - Xu2016 ER - TY - JOUR AU - Cheng, A. L. AU - Kang, Y. K. AU - Chen, Z. AU - Tsao, C. J. AU - Qin, S. AU - Kim, J. S. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR AU - Moritz, A. AU - Li, Y. AU - Guo, A. AU - Villén, J. AU - Wang, Y. AU - MacNeill, J. PY - 2010 DA - 2010// TI - Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases JO - Sci Signal VL - 3 UR - https://doi.org/10.1126/scisignal.2000998 DO - 10.1126/scisignal.2000998 ID - Moritz2010 ER - TY - JOUR AU - Wilson, T. R. AU - Fridlyand, J. AU - Yan, Y. AU - Penuel, E. AU - Burton, L. AU - Chan, E. PY - 2012 DA - 2012// TI - Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors JO - Nature VL - 487 UR - https://doi.org/10.1038/nature11249 DO - 10.1038/nature11249 ID - Wilson2012 ER - TY - JOUR AU - Atay, S. AU - Godwin, A. K. PY - 2014 DA - 2014// TI - Tumor-derived exosomes: a message delivery system for tumor progression JO - Commun Integr Biol VL - 7 UR - https://doi.org/10.4161/cib.28231 DO - 10.4161/cib.28231 ID - Atay2014 ER - TY - JOUR AU - Pol, E. AU - Böing, A. N. AU - Harrison, P. AU - Sturk, A. AU - Nieuwland, R. PY - 2012 DA - 2012// TI - Classification, functions, and clinical relevance of extracellular vesicles JO - Pharmacol Rev VL - 64 UR - https://doi.org/10.1124/pr.112.005983 DO - 10.1124/pr.112.005983 ID - Pol2012 ER - TY - JOUR AU - Regev-Rudzki, N. AU - Wilson, D. W. AU - Carvalho, T. G. AU - Sisquella, X. AU - Coleman, B. M. AU - Rug, M. PY - 2013 DA - 2013// TI - Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles JO - Cell VL - 153 UR - https://doi.org/10.1016/j.cell.2013.04.029 DO - 10.1016/j.cell.2013.04.029 ID - Regev-Rudzki2013 ER - TY - JOUR AU - Falcone, G. AU - Felsani, A. AU - D'Agnano, I. PY - 2015 DA - 2015// TI - Signaling by exosomal microRNAs in cancer JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0148-3 DO - 10.1186/s13046-015-0148-3 ID - Falcone2015 ER - TY - JOUR AU - Paladini, L. AU - Fabris, L. AU - Bottai, G. AU - Raschioni, C. AU - Calin, G. A. AU - Santarpia, L. PY - 2016 DA - 2016// TI - Targeting microRNAs as key modulators of tumor immune response JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0375-2 DO - 10.1186/s13046-016-0375-2 ID - Paladini2016 ER - TY - JOUR AU - Azmi, A. S. AU - Bao, B. AU - Sarkar, F. H. PY - 2013 DA - 2013// TI - Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review JO - Cancer Metastasis Rev VL - 32 UR - https://doi.org/10.1007/s10555-013-9441-9 DO - 10.1007/s10555-013-9441-9 ID - Azmi2013 ER - TY - JOUR AU - Junttila, M. R. AU - Sauvage, F. J. PY - 2013 DA - 2013// TI - Influence of tumour micro-environment heterogeneity on therapeutic response JO - Nature VL - 501 UR - https://doi.org/10.1038/nature12626 DO - 10.1038/nature12626 ID - Junttila2013 ER - TY - JOUR AU - Hamam, D. AU - Abdouh, M. AU - Gao, Z. H. AU - Arena, V. AU - Arena, M. AU - Arena, G. O. PY - 2016 DA - 2016// TI - Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0360-9 DO - 10.1186/s13046-016-0360-9 ID - Hamam2016 ER - TY - JOUR AU - Tang, Y. AU - Cui, Y. AU - Li, Z. AU - Jiao, Z. AU - Zhang, Y. AU - He, Y. PY - 2016 DA - 2016// TI - Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0285-3 DO - 10.1186/s13046-016-0285-3 ID - Tang2016 ER - TY - JOUR AU - Corcoran, C. AU - Rani, S. AU - O'Brien, K. AU - O'Neill, A. AU - Prencipe, M. AU - Sheikh, R. PY - 2012 DA - 2012// TI - Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0050999 DO - 10.1371/journal.pone.0050999 ID - Corcoran2012 ER - TY - JOUR AU - Xiao, X. AU - Yu, S. AU - Li, S. AU - Wu, J. AU - Ma, R. AU - Cao, H. PY - 2014 DA - 2014// TI - Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0089534 DO - 10.1371/journal.pone.0089534 ID - Xiao2014 ER - TY - JOUR AU - Safaei, R. AU - Larson, B. J. AU - Cheng, T. C. AU - Gibson, M. A. AU - Otani, S. AU - Naerdemann, W. PY - 2005 DA - 2005// TI - Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells JO - Mol Cancer Ther VL - 4 UR - https://doi.org/10.1158/1535-7163.MCT-05-0102 DO - 10.1158/1535-7163.MCT-05-0102 ID - Safaei2005 ER - TY - JOUR AU - Valadi, H. AU - Ekström, K. AU - Bossios, A. AU - Sjöstrand, M. AU - Lee, J. J. AU - Lötvall, J. O. PY - 2007 DA - 2007// TI - Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells JO - Nat Cell Biol VL - 9 UR - https://doi.org/10.1038/ncb1596 DO - 10.1038/ncb1596 ID - Valadi2007 ER - TY - JOUR AU - Lässer, C. AU - Eldh, M. AU - Lötvall, J. PY - 2012 DA - 2012// TI - Isolation and characterization of RNA-containing exosomes JO - J Vis Exp VL - 9 ID - Lässer2012 ER - TY - JOUR AU - Tian, J. AU - Tang, Z. Y. AU - Ye, S. L. AU - Liu, Y. K. AU - Lin, Z. Y. AU - Chen, J. PY - 1999 DA - 1999// TI - New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis JO - Br J Cancer VL - 81 UR - https://doi.org/10.1038/sj.bjc.6690769 DO - 10.1038/sj.bjc.6690769 ID - Tian1999 ER - TY - JOUR AU - Guan, J. AU - Chen, J. PY - 2013 DA - 2013// TI - Mesenchymal stem cells in the tumor microenvironment JO - Biomed Rep VL - 1 ID - Guan2013 ER - TY - JOUR AU - Westover, D. AU - Li, F. PY - 2015 DA - 2015// TI - New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0275-x DO - 10.1186/s13046-015-0275-x ID - Westover2015 ER - TY - JOUR AU - Ma, R. AU - Jiang, T. AU - Kang, X. PY - 2012 DA - 2012// TI - Circulating microRNAs in cancer: origin, function and application JO - J Exp Clin Cancer Res VL - 31 UR - https://doi.org/10.1186/1756-9966-31-38 DO - 10.1186/1756-9966-31-38 ID - Ma2012 ER - TY - JOUR AU - Zhang, X. AU - Yuan, X. AU - Shi, H. AU - Wu, L. AU - Qian, H. AU - Xu, W. PY - 2015 DA - 2015// TI - Exosomes in cancer: small particle, big player JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0181-x DO - 10.1186/s13045-015-0181-x ID - Zhang2015 ER - TY - JOUR AU - Kong, J. N. AU - He, Q. AU - Wang, G. AU - Dasgupta, S. AU - Dinkins, M. B. AU - Zhu, G. PY - 2015 DA - 2015// TI - Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29542 DO - 10.1002/ijc.29542 ID - Kong2015 ER - TY - JOUR AU - Shao, H. AU - Chung, J. AU - Lee, K. AU - Balaj, L. AU - Min, C. AU - Carter, B. S. PY - 2015 DA - 2015// TI - Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms7999 DO - 10.1038/ncomms7999 ID - Shao2015 ER - TY - JOUR AU - Zhong, S. AU - Chen, X. AU - Wang, D. AU - Zhang, X. AU - Shen, H. AU - Yang, S. PY - 2016 DA - 2016// TI - MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes JO - Oncotarget VL - 7 ID - Zhong2016 ER - TY - JOUR AU - Wang, J. AU - Hendrix, A. AU - Hernot, S. AU - Lemaire, M. AU - Bruyne, E. AU - Valckenborgh, E. PY - 2014 DA - 2014// TI - Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-03-562439 DO - 10.1182/blood-2014-03-562439 ID - Wang2014 ER - TY - JOUR AU - Takahashi, K. AU - Yan, I. K. AU - Kogure, T. AU - Haga, H. AU - Patel, T. PY - 2014 DA - 2014// TI - Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer JO - FEBS Open Bio VL - 4 UR - https://doi.org/10.1016/j.fob.2014.04.007 DO - 10.1016/j.fob.2014.04.007 ID - Takahashi2014 ER - TY - JOUR AU - Takahashi, K. AU - Yan, I. K. AU - Wood, J. AU - Haga, H. AU - Patel, T. PY - 2014 DA - 2014// TI - Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy JO - Mol Cancer Res VL - 12 UR - https://doi.org/10.1158/1541-7786.MCR-13-0636 DO - 10.1158/1541-7786.MCR-13-0636 ID - Takahashi2014 ER - TY - JOUR AU - Chowdhury, R. AU - Webber, J. P. AU - Gurney, M. AU - Mason, M. D. AU - Tabi, Z. AU - Clayton, A. PY - 2015 DA - 2015// TI - Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.2711 DO - 10.18632/oncotarget.2711 ID - Chowdhury2015 ER - TY - JOUR AU - Eger, A. AU - Stockinger, A. AU - Park, J. AU - Langkopf, E. AU - Mikula, M. AU - Gotzmann, J. PY - 2004 DA - 2004// TI - Beta-catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207416 DO - 10.1038/sj.onc.1207416 ID - Eger2004 ER - TY - JOUR AU - You, H. AU - Ding, W. AU - Dang, H. AU - Jiang, Y. AU - Rountree, C. B. PY - 2011 DA - 2011// TI - c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma JO - Hepatology VL - 54 UR - https://doi.org/10.1002/hep.24450 DO - 10.1002/hep.24450 ID - You2011 ER - TY - JOUR AU - Chen, W. AU - Wu, J. AU - Shi, H. AU - Wang, Z. AU - Zhang, G. AU - Cao, Y. PY - 2014 DA - 2014// TI - Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathways JO - BioMed Res Int VL - 2014 ID - Chen2014 ER -